Intravenous immunoglobulin treatment in multiple sclerosis and experimental autoimmune encephalomyelitis - The Israeli Experience

Multiple Sclerosis

Volumn 3, Issue 2, 1997, Pages 142-144

  Achiron, A ^a   Rotstein, Z ^a   Barak, Y ^a   Sarova Pinhas, I ^a   Miron, S ^a   Shinar, Y ^a   Elizur, A ^a   Noy, S ^a   Gabbay, U ^a   Gilad, R ^b   Hassin, S ^a   Goldhammer, Y ^a   Achiron, R ^c   Mashiach, S ^c   Dulitzky, M ^c   Gornish, M ^d   Mor, F ^e   Margalit, R ^e   Lider, O ^e   Cohen, I R ^e  

^a SHEBA MEDICAL CENTER   (Israel)

^b WOLFSON MEDICAL CENTER   (Israel)

^c Dept of Obstetrics and Gynecology ^*

^d RABIN MEDICAL CENTER   (Israel)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Experimental autoimmune encephalomyelitis; Intravenous immunoglobulin; Multiple sclerosis

Indexed keywords

IMMUNOGLOBULIN;

ALLERGIC ENCEPHALOMYELITIS; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; ISRAEL; MULTIPLE SCLEROSIS;

EID: 0030818474     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245859700300215     Document Type: Conference Paper

References (21)

1. Zweiman B. (1989) Theoretical mechanisms by which immunoglobulin therapy might benefit myasthenia gravis. Clin Immunol Immunopathol 53: 583-591.
2. Sandor et al. (1990) CD4+ murine T cell clones that express high levels of immunoglobulin binding belong to the interleukin-4-producing T helper cell type 2 subset. J Exp Med 171: 2171-2176.
3. Sandor et al. (1992) In vitro and in vivo activation of murine γ/δ T cells induce the expression of IgA, IgM, and IgG Fc receptors. J Immunol 148: 2363-2369.
4. Maynier M, Cosso B, Brochier J, Clot J. (1987) Identification of class II HLA alloantibodies in placenta-eluted gamma globulin used for treating rheumatoid arthritis. Arthr Rheumat 30: 375-381.
5. Wurster U, Haas J. (1994) Passage of intravenous immunoglobulin and interaction with the CNS. J Neurol Neurosurg Psychiatry 57(suppl): 21-35.
6. Rodiguez M, Lennon VA. (1990) Immunoglobulins promote remyelination in the central nervous system. Ann Neurol 27: 12-17.
7. Rodriguez M. (1991) Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest 64: 358-370.
8. Lemire JM, Weigle WO. (1986) Myelin basic protein-specific T cell clones and experimental allergic encephalomyelitis. Pathol Immunopathol Res 5: 248-252.
9. Mokhatarian VF, McFarlin DE, Raine CS. (1984) Adoptive transfer of myelin basic protein-synthesized T cells produce chronic relapsing demyelinating disease in mice. Nature 309: 356-358.
10. Achiron A et al. (1994) Intravenous immunoglobulin treatment of experimental T-cell mediated autoimmune diseases: Up-regulation of T cell proliferation and down-regulation of TNF-α secretion. J Clin In vest 93: 600-605.
11. Achiron A et al. (1994) Intravenous gammaglobulin treatment in multiple sclerosis and experimental autoimmune diseases: delineation of usage and mode of action. J Neurol Neurosurg Psychiatry 57(suppl): 57-61.
12. Rotherfelder U, Neu I, Pelka R. (1982) Therapy for multiple sclerosis with immunoglobulin G. Munch Med Wochenschr 124: 74-78.
13. Schuller E, Govaerts A. (1983) First results of immunotherapy with immunoglobulin G in multiple sclerosis patients. Eur Neurol 22: 205-212.
14. Soukop W, Tschabitscher H. (1986) Gamma globulin therapy in multiple sclerosis. Theoretical considerations and initial clinical experience with 7S immunoglobulins in MS therapy. Wien Med Wochenschr 136: 477-480.
15. Achiron et al. (1992) Open controlled therapeutic trial of high-dose intravenous immunoglobulins in relapsing-remitting multiple sclerosis. Arch Neurol 40: 1233-1236.
16. Kuitzke JF. (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-1452.
17. Achiron A et al. (1996) Intravenous immunoglobulin in multiple sclerosis: clinical and nouroradiologic results and implications for possible mechanisms of action. Clin Exp Immunol 104(suppl 1): 67-70.
18. Korn-Lubetzki I, Kahana E, Cooper G, Abramsky O. (1984) Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 16: 228-231.
19. Birk K et al. (1990) The clinical course of multiple sclerosis during pregnancy and the puerperium. Arch Neurol 47: 738-742.
20. Achiron A et al. (1996) Intravenous immunoglobulin treatment in the prevention of childbirth associated acute exacerbations in multiple sclerosis - A pilot study. J Neurol 243: 25-28.
21. Achiron A et al. (1996) Intravenous immunoglobulin in multiple sclerosis: A multicenter, double-blind, placebo-controlled trial. Neurology 46(suppl): A405-406.